Search research articles
Contact Us
Filters
Showing results (421-430 of 487) with videos related to
Page
of 49
Sort By:
Future Oncology (London, England)
|
June 27, 2025
Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus
Hampig Raphael Kourie, Mounir Ahmed Bachouchi, Malika Makhlouf Gamaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2017
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Möhrmann, Helen J Huang, David S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Oncology
|
October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion
Vivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
Investigational New Drugs
|
November 22, 2017
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
Takeo Fujii, Rivka R Colen, Mehmet Asim Bilen, et al.
JAMA Oncology
|
November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab
Reva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
British Journal of Cancer
|
April 27, 2018
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers
Shiraj Sen, Shumei Kato, Rishi Agarwal, et al.
Nature Reviews. Clinical Oncology
|
March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Clinical Genitourinary Cancer
|
August 7, 2021
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Journal for Immunotherapy of Cancer
|
February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
Jason J Luke, Fabrice Barlesi, Ki Chung, et al.
Page
of 49
Search research articles
Search
Showing results (421-430 of 487) with videos related to
Sort By:
Page
of 49
Future Oncology (London, England)
|
June 27, 2025
Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus
Hampig Raphael Kourie, Mounir Ahmed Bachouchi, Malika Makhlouf Gamaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2017
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Möhrmann, Helen J Huang, David S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Oncology
|
October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion
Vivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
Investigational New Drugs
|
November 22, 2017
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
Takeo Fujii, Rivka R Colen, Mehmet Asim Bilen, et al.
JAMA Oncology
|
November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab
Reva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
British Journal of Cancer
|
April 27, 2018
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers
Shiraj Sen, Shumei Kato, Rishi Agarwal, et al.
Nature Reviews. Clinical Oncology
|
March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Clinical Genitourinary Cancer
|
August 7, 2021
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Journal for Immunotherapy of Cancer
|
February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
Jason J Luke, Fabrice Barlesi, Ki Chung, et al.
Page
of 49